Dr. Green is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 SW 108th Ave
Ste 100
Miami, FL 33174Phone+1 305-348-3627Fax+1 305-348-4261
Summary
- T am a board-certified nephrologist with expertise in retarding the natural history of renal disease with a focus on CKD and MM,diabetic nephropathy and membranious nephropathy
Education & Training
Henry Ford Hospital/Wayne State UniversityFellowship, Nephrology, 1984 - 1987- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1981 - 1984
University of Miami Leonard M. Miller School of MedicineClass of 1981
Certifications & Licensure
FL State Medical License 1987 - 2025
MI State Medical License 1982 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- 20 citationsCatastrophic Antiphospholipid Syndrome with Severe Acute Thrombotic Microangiopathy and Hemorrhagic ComplicationsGerardo B. Vieregge, Thomas J. Harrington, David M. Andrews, Maria Carpintero, Dollie F. Green
Case Reports in Medicine. 2013-12-09 - 39 citationsA Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).Fernando C. Fervenza, Pietro A. Canetta, Sean J. Barbour, Richard A. Lafayette, Brad H. Rovin
Nephron. 2015-01-01 - 5 citationsBeyond JNC 8: implications for evaluation and management of hypertension in underserved populationsJoseph Burns, Dharam Persaud-Sharma, Dollie Green
Acta Cardiologica. 2019-01-02
Journal Articles
- Rituximab or Cyclosporinein the treatment of membranous nephropathy,NEngl.J.Med.381,36-46(2019)Fervenza,F.C., NEng,JM
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
